News
March 2020 Progress Update
Dear Colleagues, It's been an exciting few months for rotavirus vaccines, with India completing national scale-up and several other large, high-burden countries—like DRC, Benin, and Myanmar—introducing rotavirus vaccine. The evidence base describing the burden of...
Now Live! Rotavirus Disease and Immunization series of briefs
Six rotavirus-focused briefs cover epidemiology and disease burden, available vaccine products, the impact of vaccination, economic costs of rotavirus disease and the value of vaccines, safety, and introduction and coverage status. The Council’s series also includes a...
Council Webinar: Launch of Rotavirus Disease and Immunization series of briefs
Which rotavirus vaccines are globally available and what new vaccine products are in the pipeline? Which countries have achieved major reductions in hospitalization and death through the use of rotavirus vaccines? With over 95 countries currently using rotavirus...
March 2019 Progress Update
Dear Colleagues, Infants in nearly 100 countries across the world now have access to rotavirus vaccines and an estimated 54 million are vaccinated annually. There are now four globally available rotavirus vaccines, with several promising new products on the horizon....
October 2018 Update
Dear Colleagues, With the new prequalification of ROTASIIL, manufactured by Serum Institute of India, there are now four globally available rotavirus vaccines. Both ROTAVAC, prequalified in January 2018, and ROTASIIL provide different formulations and presentations...